B-cell depletion with unconjugated CD20 monoclonal antibody (mAb) is used to treat rheumatoid arthritis and other autoimmune diseases. CD20-targeted immunotherapy depletes mature B cells through ...

West Virginia University microbiologists have identified an antibody that can kill one of the most drug-resistant bacteria.

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface of B cells, which has established benefit in RA both with regards to clinical efficacy and ...

Monash University scientists have identified an immune system power play behind serious bee venom allergy, which lands twice as many Australians in hospital emergency departments each year as snake or ...

Enhances B Cell Responses in Type 2 Inflammation Through IL-17RB Receptor,” published in the January 2025 issue of Allergy ...

One of the key changes in ageing is the reduced production of immune cells. The bone marrow and thymus, which are responsible ...

Dr Matthew McKinney reflects on his first experience of treating DLBCL and highlights the advancements in emerging treatments ...

The US biotech aims to bring its antibody-based therapies to human trials later in the year and to develop new candidate ...

“The discovery that memory B cells and antibodies specific to [Nipah] persist 20 years post-infection suggests that vaccines aiming to induce long-term immunity are feasible,” said Dr Hui Ming ...

Investment company RTW Investments has launched a new biotech company called Prolium Bioscience, to advance the development ...